FL S0672

Defines "associated condition" as a symptom or side effect of cancer or its treatment that a health care provider determines would jeopardize patient health if left untreated.

Prohibits insurers and health maintenance organizations from excluding coverage for cancer treatment drugs based on lack of FDA approval if the drug is recognized in standard reference compendia or medical literature.

Prohibits insurers and health maintenance organizations from requiring that patients fail treatment with a different drug before covering prescription drugs for stage 4 metastatic cancer and associated conditions.

Requires coverage of medically necessary services associated with drug administration for any drug required by this section.

Takes effect January 1, 2021.